United Surgical Partners International Announces Third Quarter 2009 Results

http://www.businesswire.com/news/home/20091103006833/en

DALLAS--(Business Wire)--
United Surgical Partners International, Inc.:

Highlights:

* Operating income growth of 19%
* System-wide revenue growth of 11%
* U.S. same-facility revenue growth of 7%

United Surgical Partners International, Inc. ("USPI" or the "Company") today
announced results for the third quarter and nine months ended September 30,
2009.

Third Quarter Financial Results

For the quarter ended September 30, 2009, consolidated net revenues were $152.4
million compared with $153.7 million in the prior year period. On a
year-over-year basis, consolidated net revenues were reduced by $4.1 million due
to the strengthening U.S. dollar and by $9.2 million due to the deconsolidation
of facilities that are now accounted for under the equity method. Operating
income for the third quarter increased 19% to $55.4 million as compared with
$46.6 million for the prior year period. Operating income margin for the third
quarter of 2009 increased 600 basis points to 36.3% from 30.3% in the prior year
period. For the quarter, EBITDA less noncontrolling interests increased 13% to
$49.3 million from $43.6 million in the prior year period.

The operating results in the quarter were driven by strong same-facility revenue
growth and an increase in margins. The improvement in margins was a result of an
increase in volume at recently developed or expanded facilities along with
improved expense management. Same-facility margins in the U.S. increased 160
basis points. In addition, consolidated margins were benefited by the continued
growth in equity in earnings of unconsolidated affiliates, which grew 31% in the
third quarter.

In the three months ended September 30, 2009, the Company`s tax provision
includes the recognition of a $31.5 million U.S. income tax benefit. This
benefit, which encompasses the Company`s net operating loss carryforwards and
most other U.S. deferred tax assets, has been recognized because the Company
considers it more likely than not that taxable income will be generated in the
future to allow those assets to be realized.

Cash flows from operating activities for the third quarter totaled $68.5 million
compared with $44.2 million for the prior year period. During the third quarter,
the Company and its consolidated subsidiaries invested approximately $3.2
million in maintenance capital expenditures and an additional $2.7 million to
develop new facilities and expand existing facilities.

Nine Month Financial Results

For the nine months ended September 30, 2009, consolidated net revenues were
$465.9 million compared with $482.0 million in the prior year nine-month period.
Operating income for the first nine months of 2009 increased 16% to $169.1
million as compared with $145.5 million for the same period of 2008. Operating
income margin for the nine months ended September 30, 2009, increased 610 basis
points to 36.3% from 30.2% in the prior year nine-month period. For the first
nine months of 2009, EBITDA less noncontrolling interests increased 13% to
$148.5 million from $132.0 million in the prior year nine-month period. On a
year-over-year basis, the strengthening of the U.S. dollar reduced net revenue
and operating income by $19.9 million and $4.3 million, respectively.

Cash flows from operating activities for the nine months ended September 30,
2009, totaled $145.2 million, compared with $107.8 million for the prior year
nine-month period. During the first nine months of 2009, the Company and its
consolidated subsidiaries invested approximately $9.3 million in maintenance
capital expenditures and an additional $7.7 million to develop new facilities
and expand existing facilities.

System-Wide Financial Results

Due to the significance of unconsolidated facilities to the Company`s business
and because the Company`s net earnings from a facility are the same whether the
Company consolidates it or not, the Company primarily analyzes its financial
results by treating all facilities as though they were consolidated by the
Company, a grouping the Company refers to as system-wide financial results. The
Company believes that system-wide financial results provide a useful indicator
of the underlying fundamentals of the business (see Statement of Income -
Reconciliation of Non-GAAP Financial Measures) by providing more information
about where the Company`s increase in earnings is coming from. Specifically,
system-wide financial results demonstrate that an increase in revenues at
Company facilities, together with the leveraging of facility-level expenses, led
to increased earnings for the Company during the three months and nine months
ended September 30, 2009, even though the Company`s reported revenues, which
only include consolidated facilities, decreased compared with prior periods. The
strong growth within the unconsolidated facilities reflects the success of the
Company`s three-way joint venture model and the disproportionate investment that
the Company has made in that model in recent years.

Third Quarter System-Wide Financial Results

For the quarter ended September 30, 2009, system-wide net revenues increased 11%
to $434.1 million from $392.7 million in the prior year period. This increase
was primarily a result of a 7% increase in U.S. same-facility net revenue.
System-wide operating income for the third quarter of 2009 increased 20% to
$112.8 million from $93.7 million, and operating income margins were up 210
basis points to 26.0% from 23.9% in the prior year period.

Nine Month System-Wide Financial Results

For the nine months ended September 30, 2009, system-wide net revenues increased
9% to $1.3 billion from $1.2 billion in the prior year nine-month period. This
increase was primarily a result of an 8% increase in U.S. same-facility net
revenue. System-wide operating income for the nine months ended September 30,
2009, increased 21% to $341.2 million from $282.0 million, and operating income
margins were up 260 basis points to 26.6% from 24.0% in the prior year
nine-month period.

Revenue Analysis

The revenues of the facilities operated by the Company increased on a
year-over-year basis, but consolidated and system-wide revenues were also
affected by other transactions and a strengthening U.S. dollar. The table below
lists the key drivers of year-over-year changes in revenues.

Three Months Ended Nine Months Ended
September 30, 2009 September 30, 2009
As Reported System-Wide As Reported System-Wide

Under GAAP
Under GAAP
Total revenues, period ended September 30, 2008 $ 153,663 $ 392,714 $ 481,965 $ 1,173,989
Add: Revenue from acquired facilities 6,820 24,473 20,883 71,783
Less: Revenue of disposed facilities - (5,556 ) - (19,127 )
Less: Revenue of deconsolidated facilities (9,185 ) - (32,678 ) -
Other payor adjustments - - 78 (7,985 )
Impact of exchange rate (4,076 ) (4,076 ) (19,941 ) (19,941 )
Adjusted base period 147,222 407,555 450,307 1,198,719
Operating growth 3,552 26,282 13,513 85,320
Non-facility based revenue 1,607 250 2,067 401
Total revenues, period ended September 30, 2009 $ 152,381 $ 434,087 $ 465,887 $ 1,284,440

Development Activity

Year to date, the Company has added seven facilities and completed the sale of
its interests in four facilities. The Company expects to add ten to 15
facilities in 2009 through a blend of de novo facilities and acquisitions.
Currently, eight facilities are in development, of which one is under
construction. In addition to the four divestitures, the Company deconsolidated
the financial results of three facilities.

Commenting on the results, William H. Wilcox, USPI`s chief executive officer,
said, "We are generally pleased with our results of operations for the quarter,
though somewhat disappointed in our same-facility volume growth. From a
development perspective, while our pace this year is slow compared with
historical levels, we are quite optimistic about our acquisition and de novo
opportunities. Finally, while we do not know the outcome of healthcare reform,
our industry is well positioned as a high quality provider that yields
significant savings to Medicare and its beneficiaries."

Impact of Adoption of SFAS No. 160

Effective January 1, 2009, the Company adopted Statement of Financial Accounting
Standards No. 160, "Noncontrolling Interests in Consolidated Financial
Statements, an Amendment of Accounting Research Bulletin No. 51," now codified
in the FASB`s Accounting Standards Codification, Topic 810, Consolidation ("ASC
810") which requires changes to the financial statement presentation. Net income
attributable to noncontrolling interests, previously referred to as minority
interests in the income of consolidated subsidiaries, is now reported after net
earnings. This change results in pretax income being subtotaled before net
income attributable to noncontrolling interests has been subtracted.

In addition, a portion of the noncontrolling interests in the Company`s
subsidiaries is now included as a component of total equity on the Company`s
consolidated balance sheet. Cash flows related to noncontrolling interests are
also classified differently under ASC 810. Cash flows from operating activities
no longer include distributions of earnings to noncontrolling interests; under
ASC 810 those amounts are classified within financing activities, as are certain
amounts previously classified within investing activities. The impact of all of
these presentation changes has been reflected in all periods presented.

The live broadcast of USPI`s third quarter conference call will begin at 10:00
a.m. Eastern Time on November 4, 2009. A 30-day online replay will be available
approximately an hour following the conclusion of the live broadcast. A link to
these events can be found on the Company`s website at www.unitedsurgical.com or
at www.earnings.com. Additional financial information pertaining to United
Surgical Partners International may be found by visiting the Investor Relations
section of the Company`s website.

USPI, headquartered in Dallas, Texas, currently has ownership interests in or
operates 169 surgical facilities. Of the Company`s 165 domestic facilities, 106
are jointly owned with not-for-profit healthcare systems. The Company also
operates four facilities in London, England.

The above includes forward-looking statements based on current management
expectations.Numerous factors exist that may cause results to differ from these
expectations.Many of the factors that will determine the Company`s future
results are beyond the ability of the Company to control or predict.These
statements are subject to risks and uncertainties relating to the Company,
including without limitation, (i) reduction in reimbursement from payors; (ii)
the Company`s ability to attract physicians and retain qualified management and
personnel; (iii) the Company`s significant leverage; (iv) geographic
concentrations of certain of the Company`s operations; (v) risks associated with
the Company`s acquisition and development strategies; (vi) the regulated nature
of the healthcare industry; (vii) the highly competitive nature of the
healthcare business; and (viii) those risks and uncertainties described from
time to time in the Company`s filings with the Securities and Exchange
Commission.Therefore, the Company`s actual results may differ materially.The
Company undertakes no obligation to update any forward-looking statements or to
make any other forward-looking statements, whether as a result of new
information, future events or otherwise.

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Unaudited Condensed Consolidated Statements of Income

(in thousands, except number of facilities)

Three Months Ended Nine Months Ended

September 30,
September 30,
2009 2008 2009 2008
Revenues $ 152,381 $ 153,663 $ 465,887 $ 481,965

Equity in earnings of unconsolidated affiliates 14,913 11,420 43,110 32,563

Operating expenses:
Salaries, benefits and other employee costs 44,223 45,172 130,089 138,820
Medical services and supplies 25,451 27,338 76,019 85,183
Other operating expenses 21,210 25,188 69,904 81,391
General and administrative expenses 9,609 9,766 29,708 29,933
Provision for doubtful accounts 2,674 2,146 7,553 5,956
Depreciation and amortization 8,745 8,856 26,610 27,702
Total operating expenses 111,912 118,466 339,883 368,985
Operating income 55,382 46,617 169,114 145,543
Interest expense, net (17,069 ) (20,474 ) (51,123 ) (62,602 )
Other, net (8,925 ) (708 ) (19,145 ) (463 )
Income from continuing operations before income taxes 29,388 25,435 98,846 82,478
Income tax benefit (expense) 24,123 (6,074 ) 9,504 (18,686 )
Income from continuing operations 53,511 19,361 108,350 63,792
Discontinued operations, net of tax - (9 ) - (898 )
Net income 53,511 19,352 108,350 62,894
Less: Net income attributable to noncontrolling interests (14,807 ) (11,911 ) (47,207 ) (41,269 )
Net income attributable to USPI`s common stockholder $ 38,704 $ 7,441 $ 61,143 $ 21,625

Supplemental Data:
Facilities operated at period end 167 158 167 158

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Unaudited Condensed Consolidated Balance Sheets

(in thousands)

Sept. 30, Dec. 31,
2009 2008

ASSETS

Current assets:
Cash and cash equivalents $ 156,543 $ 49,435
Accounts receivable, net of allowance for doubtful accounts of $8,691 and $11,544, respectively 53,047 57,213
Other receivables 18,148 17,070
Inventories 8,310 9,079
Deferred tax assets, net 17,094 -
Other 13,720 11,735
Total current assets 266,862 144,532

Property and equipment, net 191,633 201,824
Investments in unconsolidated affiliates 315,561 307,771
Goodwill and intangible assets, net 1,591,132 1,589,139
Other 25,582 24,897
Total assets $ 2,390,770 $ 2,268,163

LIABILITIES AND EQUITY

Current liabilities:
Accounts payable $ 18,206 $ 22,194
Accrued expenses and other 211,488 136,688
Current portion of long-term debt 22,627 24,488
Total current liabilities 252,321 183,370

Long-term debt 1,047,233 1,073,459
Other liabilities 155,203 153,156
Total liabilities 1,454,757 1,409,985

Noncontrolling interests - redeemable 57,462 52,214

USPI stockholder`s equity 842,890 764,137
Noncontrolling interests - nonredeemable 35,661 41,827
Total equity 878,551 805,964
Total liabilities and equity $ 2,390,770 $ 2,268,163

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.
Statements of Income - Reconciliation of Non-GAAP Financial Measures
(in thousands)

System-Wide Operating Results
USPI conducts the majority of its business through facilities that the Company accounts for under the equity method. Of the Company`s 167 facilities at September 30, 2009, the Company accounted for 106 under the equity method.

Because the Company`s net earnings from a facility are the same whether the Company consolidates it or not, the primary way the Company analyzes its business ignores the distinction between consolidated versus equity method facilities. Viewing USPI`s business in this manner makes it easier to analyze the overall growth rate of its business and the operating margins of all the facilities driving the Company`s net earnings. The following tables depict USPI`s business as though it consolidated all of its
facilities, which is a non-GAAP measure, and reconciles these system-wide results to the Company`s consolidated statements of income prepared under GAAP (see footnote explanations on page 10):

Three Months Ended September 30, 2009
System- Unconsolidated Consolidation As Reported

Wide(1)
Affiliates(2)
Adjustments
Under GAAP
Revenues $ 434,087 $ (293,207 ) $ 11,501 $ 152,381

Equity in earnings of unconsolidated affiliates - - 14,913 14,913

Operating expenses:
Salaries, benefits and other employee costs 115,614 (71,391 ) - 44,223
Medical services and supplies 93,537 (68,086 ) - 25,451
Other operating expenses 70,517 (60,808 ) 11,501 21,210
General and administrative expenses 9,609 - - 9,609
Provision for doubtful accounts 10,584 (7,910 ) - 2,674
Depreciation and amortization 21,390 (12,645 ) - 8,745
Total operating expenses 321,251 (220,840 ) 11,501 111,912
Operating income 112,836 (72,367 ) 14,913 55,382

Interest income 609 (89 ) - 520
Interest expense (23,719 ) 6,130 - (17,589 )
Other, net (8,087 ) (838 ) - (8,925 )
Total other expense, net (31,197 ) 5,203 - (25,994 )
Income before income taxes 81,639 (67,164 ) 14,913 29,388
Income tax (expense) benefit 22,415 1,708 - 24,123
Net income 104,054 (65,456 ) 14,913 53,511
Less: Net income attributable to noncontrolling interests (65,350 ) - 50,543 (14,807 )
Net income attributable to USPI`s common stockholder(6) $ 38,704 $ (65,456 ) $ 65,456 $ 38,704

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Statements of Income - Reconciliation of Non-GAAP Financial Measures (Continued)

(in thousands)

Nine Months Ended September 30, 2009
System- Unconsolidated Consolidation As Reported

Wide(1)
Affiliates(2)
Adjustments
Under GAAP
Revenues $ 1,284,440 $ (852,679 ) $ 34,126 $ 465,887

Equity in earnings of unconsolidated affiliates - - 43,110 43,110

Operating expenses:
Salaries, benefits and other employee costs 334,574 (204,485 ) - 130,089
Medical services and supplies 270,992 (194,973 ) - 76,019
Other operating expenses 216,409 (180,631 ) 34,126 69,904
General and administrative expenses 29,708 - - 29,708
Provision for doubtful accounts 27,453 (19,900 ) - 7,553
Depreciation and amortization 64,084 (37,474 ) - 26,610
Total operating expenses 943,220 (637,463 ) 34,126 339,883
Operating income 341,220 (215,216 ) 43,110 169,114

Interest income 2,625 (364 ) - 2,261
Interest expense (72,060 ) 18,676 - (53,384 )
Other, net (16,968 ) (2,177 ) - (19,145 )
Total other expense, net (86,403 ) 16,135 - (70,268 )
Income before income taxes 254,817 (199,081 ) 43,110 98,846
Income tax (expense) benefit 4,698 4,806 - 9,504
Net income 259,515 (194,275 ) 43,110 108,350
Less: Net income attributable to noncontrolling interests (198,372 ) - 151,165 (47,207 )
Net income attributable to USPI`s common stockholder(6) $ 61,143 $ (194,275 ) $ 194,275 $ 61,143

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Statements of Income - Reconciliation of Non-GAAP Financial Measures (Continued)

(in thousands)

Three Months Ended September 30, 2008
System- Unconsolidated Consolidation As Reported

Wide(1)
Affiliates(2)
Adjustments
Under GAAP
Revenues $ 392,714 $ (248,691 ) $ 9,640 (3) $ 153,663

Equity in earnings of unconsolidated affiliates - - 11,420 (4) 11,420

Operating expenses:
Salaries, benefits and other employee costs 107,915 (62,743 ) - 45,172
Medical services and supplies 80,134 (52,796 ) - 27,338
Other operating expenses 70,254 (54,706 ) 9,640 (3) 25,188
General and administrative expenses 9,766 - - 9,766
Provision for doubtful accounts 10,223 (8,077 ) - 2,146
Depreciation and amortization 20,695 (11,839 ) - 8,856
Total operating expenses 298,987 (190,161 ) 9,640 118,466
Operating income 93,727 (58,530 ) 11,420 46,617

Interest income 1,099 (414 ) - 685
Interest expense (27,676 ) 6,517 - (21,159 )
Other, net 157 (865 ) - (708 )
Total other expense, net (26,420 ) 5,238 - (21,182 )
Income from continuing operations before income taxes 67,307 (53,292 ) 11,420 25,435
Income tax expense (7,405 ) 1,331 - (6,074 )
Income from continuing operations 59,902 (51,961 ) 11,420 19,361
Discontinued operations, net of tax (9 ) - - (9 )
Net income 59,893 (51,961 ) 11,420 19,352
Less: Net income attributable to noncontrolling interests (52,452 ) - 40,541 (5) (11,911 )
Net income attributable to USPI`s common stockholder(6) $ 7,441 $ (51,961 ) $ 51,961 $ 7,441

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Statements of Income - Reconciliation of Non-GAAP Financial Measures (Continued)

(in thousands)

Nine Months Ended September 30, 2008
System- Unconsolidated Consolidation As Reported

Wide(1)
Affiliates(2)
Adjustments
Under GAAP
Revenues $ 1,173,989 $ (721,035 ) $ 29,011 (3) $ 481,965

Equity in earnings of unconsolidated affiliates 13 (13 ) 32,563 (4) 32,563

Operating expenses:
Salaries, benefits and other employee costs 319,016 (180,196 ) - 138,820
Medical services and supplies 236,757 (151,574 ) - 85,183
Other operating expenses 212,658 (160,278 ) 29,011 (3) 81,391
General and administrative expenses 29,933 - - 29,933
Provision for doubtful accounts 29,496 (23,540 ) - 5,956
Depreciation and amortization 64,192 (36,490 ) - 27,702
Total operating expenses 892,052 (552,078 ) 29,011 368,985
Operating income 281,950 (168,970 ) 32,563 145,543

Interest income 3,841 (1,332 ) - 2,509
Interest expense (84,750 ) 19,639 - (65,111 )
Other, net 1,838 (2,301 ) - (463 )
Total other expense, net (79,071 ) 16,006 - (63,065 )
Income from continuing operations before income taxes 202,879 (152,964 ) 32,563 82,478
Income tax expense (22,667 ) 3,981 - (18,686 )
Income from continuing operations 180,212 (148,983 ) 32,563 63,792
Discontinued operations, net of tax (898 ) - - (898 )
Net income 179,314 (148,983 ) 32,563 62,894
Less: Net income attributable to noncontrolling interests (157,689 ) - 116,420 (5) (41,269 )
Net income attributable to USPI`s common stockholder(6) $ 21,625 $ (148,983 ) $ 148,983 $ 21,625

(1) Our system-wide statements of income treat all of our facilities as though they were consolidated subsidiaries. Our consolidated system-wide statement of income is not a
measure defined under GAAP because it includes the revenues and expenses of entities we do not control and thus do not consolidate for financial reporting purposes under
GAAP. We believe that system-wide revenues, expenses, and operating margins are important to understanding our business, since these measures include the health of the
unconsolidated operating entities that comprise over 60% of our facilities. For example, these facilities` growth in revenues directly affects our earnings in the form of
management fees we earn for operating the facilities, as well as indicating the degree to which we are growing revenues and leveraging costs at these facilities, which
are the key drivers of our net income. Our definition of system-wide statement of income may differ materially from similarly titled measures of other companies. Our
system-wide net income attributable to USPI`s common stockholder is the same as our net income attributable to USPI`s common stockholder reported under GAAP.
(2) Subtracts the aggregated revenues and expenses of our unconsolidated affiliates.
(3) Our system-wide statements of income include consolidation entries that eliminate management fee revenues (on USPI`s financial records) and expenses (on the facilities`
financial records). Under GAAP, these consolidation entries need to be removed with respect to amounts charged to unconsolidated affiliates, as under GAAP these are not
intercompany transactions with consolidated subsidiaries.
(4) Records our share of the net income of our unconsolidated affiliates.
(5) Our system-wide statement of income includes noncontrolling interest expense for the portion of investees` earnings not owned by us. Under GAAP, there is no
noncontrolling interest expense recorded with respect to unconsolidated affiliates.
(6) As the net impact of items (2) through (5) is zero, system-wide net income attributable to USPI`s common stockholder equals the net income attributable to USPI`s common
stockholder that we report under GAAP.

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

Key Operating Statistics

Three Months Ended September 30,
2009 2008 % Change
System-wide statistics (in thousands):
Revenue $ 434,087 $ 392,714 10.5 %
Operating income 112,836 93,727 20.4 %

System-wide same-facility statistics(1):
United States(2)
Facility cases 185,817 181,880 2.2 %

Net revenue/case $ 2,122 $ 2,022 4.9 %

Net revenue (in thousands) $ 394,243 $ 367,801 7.2 %

Facility operating income margin(3) 26.1 % 24.5 % 160 bps

United Kingdom:
Adjusted admissions 5,668 5,752 (1.5 %)
Net revenue/adjusted admission $ 4,794 $ 5,368 (10.7 %)
Net revenue/adjusted admission (at constant currency translation rates)(4) $ 4,794 $ 4,663 2.8 %
Net revenue (in thousands) $ 27,171 $ 30,877 (12.0 %)
Facility operating income margin(3) 22.7 % 24.5 % (180) bps

Other:
Total consolidated facilities 60 60

EBITDA less noncontrolling interests(5)(in thousands):
GAAP operating income $ 55,382 $ 46,617 18.8 %
Depreciation and amortization 8,745 8,856
EBITDA 64,127 55,473
Net income attributable to noncontrolling interests (14,807 ) (11,911 )
EBITDA less noncontrolling interests $ 49,320 $ 43,562 13.2 %

(1) Excludes facilities in their first year of operations. Includes facilities accounted for under the equity method as well as consolidated facilities.
(2) Statistics are included in both periods for current year acquisitions.
(3) Calculated as operating income divided by net revenue.
(4) Calculated using third quarter 2009 exchange rates. The Company believes net revenue per adjusted admission is an important measure of the United Kingdom operations and
that using a constant currency translation rate more accurately reflects the trend of the business.
(5) EBITDA and EBITDA less noncontrolling interests are not measures defined under GAAP. The Company believes EBITDA and EBITDA less noncontrolling interests are important
measures for purposes of allocating resources and assessing performance. EBITDA, which is computed by adding operating income plus depreciation and amortization, is
commonly used as an analytical indicator within the healthcare industry and also serves as a measure of leverage capacity and debt service ability. EBITDA less
noncontrolling interests, which is computed by subtracting net income attributable to noncontrolling interests from EBITDA, adjusts both years` EBITDA to reflect that the
Company does not own 100% of each facility. EBITDA and EBITDA less noncontrolling interests should not be considered as measures of financial performance under generally
accepted accounting principles, and the items excluded from EBITDA and EBITDA less noncontrolling interests are significant components in understanding and assessing
financial performance. Because EBITDA and EBITDA less noncontrolling interests are not measurements determined in accordance with generally accepted accounting principles
and are thus susceptible to varying calculation methods, EBITDA and EBITDA less noncontrolling interests as presented by United Surgical Partners International may not be
comparable to similarly titled measures of other companies.

United Surgical Partners International, Inc.
Mark A. Kopser, 972-713-3500
Executive Vice President and Chief Financial Officer

Copyright Business Wire 2009